Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Thyroid eye disease: Redefining its management-A review.
Jain AP, Jaru-Ampornpan P, Douglas RS. Jain AP, et al. Among authors: douglas rs. Clin Exp Ophthalmol. 2021 Mar;49(2):203-211. doi: 10.1111/ceo.13899. Epub 2021 Jan 22. Clin Exp Ophthalmol. 2021. PMID: 33484076 Review.
Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique.
Douglas RS, Tsirbas A, Gordon M, Lee D, Khadavi N, Garneau HC, Goldberg RA, Cahill K, Dolman PJ, Elner V, Feldon S, Lucarelli M, Uddin J, Kazim M, Smith TJ, Khanna D; International Thyroid Eye Disease Society. Douglas RS, et al. Arch Ophthalmol. 2009 Sep;127(9):1155-60. doi: 10.1001/archophthalmol.2009.232. Arch Ophthalmol. 2009. PMID: 19752424 Free PMC article.
Immunopathogenesis of thyroid eye disease: emerging paradigms.
Naik VM, Naik MN, Goldberg RA, Smith TJ, Douglas RS. Naik VM, et al. Among authors: douglas rs. Surv Ophthalmol. 2010 May-Jun;55(3):215-26. doi: 10.1016/j.survophthal.2009.06.009. Surv Ophthalmol. 2010. PMID: 20385333 Free PMC article. Review.
Teprotumumab for Thyroid-Associated Ophthalmopathy.
Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS. Smith TJ, et al. Among authors: douglas rs. N Engl J Med. 2017 May 4;376(18):1748-1761. doi: 10.1056/NEJMoa1614949. N Engl J Med. 2017. PMID: 28467880 Free PMC article. Clinical Trial.
Non-surgical treatment for eyelid retraction in thyroid eye disease (TED).
Grisolia ABD, Couso RC, Matayoshi S, Douglas RS, Briceño CA. Grisolia ABD, et al. Among authors: douglas rs. Br J Ophthalmol. 2017 Aug 9:bjophthalmol-2017-310695. doi: 10.1136/bjophthalmol-2017-310695. Online ahead of print. Br J Ophthalmol. 2017. PMID: 28794075 Review.
A New Era in the Treatment of Thyroid Eye Disease.
Patel A, Yang H, Douglas RS. Patel A, et al. Among authors: douglas rs. Am J Ophthalmol. 2019 Dec;208:281-288. doi: 10.1016/j.ajo.2019.07.021. Epub 2019 Aug 1. Am J Ophthalmol. 2019. PMID: 31377284 Free article. Review.
128 results